Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dexamethasone metabolism in vitro: species differences

E S Tomlinson1, J L Maggs, B K Park

  • 1Department of Pharmacology and Therapeutics, University of Liverpool, UK.

The Journal of Steroid Biochemistry and Molecular Biology
|July 1, 1997
PubMed
Summary

This study compared dexamethasone (DEX) metabolism across species. Male rats showed the most similar metabolic profile to humans, while hamsters exhibited the highest 6-hydroxylation by CYP3A.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-low-dose computed tomography (CT) protocol for guiding cryoablation in treating a T1a renal cell carcinoma (RCC): radiation doses and treatment outcomes.

Clinical radiology·2025
Same author

Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Theileria buffeli infections in grazing cattle in the Republic of Korea.

Tropical biomedicine·2021
Same author

Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response.

Journal of proteomics·2018
Same author

Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.

Expert opinion on drug metabolism & toxicology·2018
Same author

Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Biochemistry

Background:

  • Dexamethasone (DEX) undergoes extensive metabolism in humans, primarily via CYP3A4, producing 6-hydroxyDEX (6OH-DEX) and side-chain cleaved products.
  • Understanding interspecies differences in DEX metabolism is crucial for selecting appropriate animal models in preclinical research.

Purpose of the Study:

  • To investigate and compare the metabolic profiles of [3H]DEX in liver fractions from various mammalian species.
  • To identify species-specific metabolic pathways and compare them to human liver metabolism.
  • To evaluate the utility of different species as models for studying DEX metabolism, particularly CYP3A-mediated pathways.

Main Methods:

  • Incubation of [3H]DEX with liver microsomes and cytosol from different mammalian species.

Related Experiment Videos

  • Quantification of metabolites using radiometric high-pressure liquid chromatography (HPLC).
  • Characterization of metabolites using liquid chromatography-mass spectrometry (LC-MS) and co-chromatography with standards. Ketoconazole and glycyrrhetinic acid were used as inhibitors.
  • Main Results:

    • Significant quantitative and qualitative species differences in DEX metabolite profiles were observed.
    • 6-Hydroxylation of DEX varied across species, being highest in hamsters, and showed sex-specific differences in rats (male >> female).
    • Ketoconazole's inhibition of 6-hydroxylation was variable, questioning its selectivity across all species. A reductive metabolite (M5) was identified in cytosolic incubations.

    Conclusions:

    • The male rat exhibited a DEX metabolite profile most closely resembling that of humans.
    • Hamsters demonstrated the most extensive 6-hydroxylation, suggesting their potential as a model for CYP3A-mediated DEX metabolism studies.
    • Species-specific metabolic pathways and the variable efficacy of CYP3A inhibitors highlight the complexity of interspecies drug metabolism extrapolation.